Annual Short Term Debt
$1.78 M
+$1.35 M+312.24%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual short term debt is $1.78 million, with the most recent change of +$1.35 million (+312.24%) on December 31, 2023.
- During the last 3 years, BRNS annual short term debt has risen by +$1.59 million (+829.69%).
- BRNS annual short term debt is now at all-time high.
Performance
BRNS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.99 M
+$70.00 K+3.65%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly short term debt is $1.99 million, with the most recent change of +$70.00 thousand (+3.65%) on September 30, 2024.
- Over the past year, BRNS quarterly short term debt has stayed the same.
- BRNS quarterly short term debt is now at all-time high.
Performance
BRNS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
BRNS Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +312.2% | 0.0% |
| 3 y3 years | +829.7% | +358.7% |
| 5 y5 years | +937.8% | +883.2% |
BRNS Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +312.2% | at high | +967.7% |
| 5 y | 5-year | at high | +937.8% | at high | +967.7% |
| alltime | all time | at high | +937.8% | at high | +967.7% |
Barinthus Biotherapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.99 M(+3.7%) |
| Jun 2024 | - | $1.92 M(+0.4%) |
| Mar 2024 | - | $1.91 M(+6.9%) |
| Dec 2023 | $1.78 M(+312.2%) | $1.78 M(+18.9%) |
| Sep 2023 | - | $1.50 M(+32.2%) |
| Jun 2023 | - | $1.14 M(+74.9%) |
| Mar 2023 | - | $649.00 K(+49.9%) |
| Dec 2022 | $433.00 K | $433.00 K(+132.8%) |
| Sep 2022 | - | $186.00 K(-37.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $299.00 K(-9.7%) |
| Mar 2022 | - | $331.00 K(-51.5%) |
| Dec 2021 | $682.00 K(+255.2%) | - |
| Dec 2021 | - | $682.00 K(+56.8%) |
| Sep 2021 | - | $435.00 K(+115.3%) |
| Jun 2021 | - | $202.00 K(+2.0%) |
| Mar 2021 | - | $198.00 K(+3.1%) |
| Dec 2020 | $192.00 K(+11.6%) | $192.00 K |
| Dec 2019 | $172.00 K | - |
FAQ
- What is Barinthus Biotherapeutics annual short term debt?
- What is the all time high annual short term debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual short term debt year-on-year change?
- What is Barinthus Biotherapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly short term debt year-on-year change?
What is Barinthus Biotherapeutics annual short term debt?
The current annual short term debt of BRNS is $1.78 M
What is the all time high annual short term debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual short term debt is $1.78 M
What is Barinthus Biotherapeutics annual short term debt year-on-year change?
Over the past year, BRNS annual short term debt has changed by +$1.35 M (+312.24%)
What is Barinthus Biotherapeutics quarterly short term debt?
The current quarterly short term debt of BRNS is $1.99 M
What is the all time high quarterly short term debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly short term debt is $1.99 M
What is Barinthus Biotherapeutics quarterly short term debt year-on-year change?
Over the past year, BRNS quarterly short term debt has changed by $0.00 (0.00%)